Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: A Danish nationwide cohort study
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | British Journal of Dermatology, Supplement |
ISSN | 0366-077X |
DOI |
|
Status | E-pub ahead of print - 2024 |
ID: 386608261